Fulltext

Isolated systolic hypertension in Asia

Tsai TY 1 , Cheng HM 1 , Chuang SY 2 , Chia YC 3 , Soenarta AA 4 , Minh HV 5 Show all authors , Siddique S 6 , Turana Y 7 , Tay JC 8 , Kario K 9 , Chen CH 1

Affiliations 

  • 1 Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan
  • 2 Institute of Population Health Science, National Health Research Institutes, Miaoli, Taiwan
  • 3 Department of Medical Sciences, School of Healthcare and Medical Sciences, Sunway University, Bandar Sunway, Malaysia
  • 4 Department of Cardiology and Vascular Medicine, Faculty of Medicine, Harapan Kita, University of Indonesia-National Cardiovascular Center, Jakarta, Indonesia
  • 5 Department of Internal Medicine, University of Medicine and Pharmacy, Hue University, Hue City, Vietnam
  • 6 Fatima Memorial Hospital, Lahore, Pakistan
  • 7 School of Medicine and Health Sciences, Atma Jaya Catholic University of Indonesia, Jakarta, Indonesia
  • 8 Department of General Medicine, Tan Tock Seng Hospital, Singapore, Singapore
  • 9 Division of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Tochigi, Japan
J Clin Hypertens (Greenwich), 2021 03;23(3):467-474.
PMID: 33249701 DOI: 10.1111/jch.14111

Abstract

Isolated systolic hypertension (ISH) is the most common type of essential hypertension in the elderly and young adults. With rapid industrialization and population aging, the prevalence of ISH in Asia will rise substantially. Asian populations have distinct epidemiological features, risk factors and are especially vulnerable to ISH. There is a pressing need for Asian countries to formulate their unique strategies for control of ISH. In this review, we focus on the (1) epidemiology and pathophysiology, (2) risk factors and impact on outcomes, and (3) treatment goal and strategy for ISH in Asia.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

MeSH terms
Similar publications